Good Enough Shrink

The Shortage of Stimulant Medications for ADHD - Why It's Still a Problem Today

Dr. Jenna Cheng, Dr. Patrick Kelly Season 1 Episode 3

In this episode, we take a quick break from attachment theory and dive into a very real, current problem we face today: the stimulant medication shortage for the treatment of ADHD. We explore the complex regulatory systems surrounding stimulants, including supply chain issues and being lumped into the category of Schedule II medications monitored by the Drug Enforcement Agency (DEA) to fight the Opioid Epidemic. The pressures from many layers of control fall on the shoulders of the pharmacist, and worst of all, the patients. Lastly, we discuss how to mitigate this shortage issue for patients, and the need for patient advocacy amongst clinicians. 

Have questions for us, or feedback about our podcast? Send us a message!

People on this episode

Podcasts we love

Check out these other fine podcasts recommended by us, not an algorithm.

The Carlat Psychiatry Podcast Artwork

The Carlat Psychiatry Podcast

Pocket Psychiatry: A Carlat Podcast
Psychopharmacology and Psychiatry Updates Artwork

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute
Good Inside with Dr. Becky Artwork

Good Inside with Dr. Becky

Dr. Becky Kennedy
Being Well with Forrest Hanson and Dr. Rick Hanson Artwork

Being Well with Forrest Hanson and Dr. Rick Hanson

Rick Hanson, Ph.D., Forrest Hanson
Journal of the American Academy of Child and Adolescent Psychiatry Artwork

Journal of the American Academy of Child and Adolescent Psychiatry

American Academy of Child and Adolescent Psychiatry
American Journal of Psychiatry Audio Artwork

American Journal of Psychiatry Audio

American Journal of Psychiatry